Can OI prophylaxis be stopped in patients responding to HAART?
Boyle
B A
BA
Center for Special Studies, Division of International Medicine and Infectious Disease, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D003657:Decision Making; D006801:Humans; D009894:Opportunistic Infections / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination